BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01229150-completion@plaintrial.com
DTSTAMP:20260928T144650Z
DTSTART;VALUE=DATE:20151121
SUMMARY:Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kin
 ase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non
 -Small Cell Lung Cancer (NSCLC) and a Randomized Phase II Study of AZD6244
  With Erlotinib in Mutant KRAS Adva... — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT01229150
URL:https://plaintrial.com/trial/NCT01229150
END:VEVENT
END:VCALENDAR